X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswireindia.com/lintonpharm-announces-authorization-from-china-health-authority-nmpa-to-proceed-with-a-phase-1by2-trial-evaluating-catumaxomab-for-the-treatment-of-non-muscle-invasive-bladder-cancer-72506.html